Robotic radical prostatectomy after aborted prostatectomy: still feasible? The experience from a tertiary care center.


Journal

Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 03 08 2018
accepted: 25 08 2018
pubmed: 31 8 2018
medline: 14 11 2019
entrez: 31 8 2018
Statut: ppublish

Résumé

To describe the surgical management of patients who had radical prostatectomy previously attempted but aborted due to diverse causes. Patients who underwent an "aborted prostatectomy" were extracted from the institutional prostatectomy database. A description of the tailored robotic approach was reported for each case. Tips and tricks for the accomplishment of robotic prostatectomy after aborted prostatectomy were reported. Six clinical cases were analyzed. Three patients had aborted prostatectomy due to complicated dissection hindered by pelvic mesh and bowel adhesions; one prostatectomy was aborted due to anesthesiology/respiratory matters; one for narrow pelvis; one due to abnormal pelvic vascular anatomy. All patients successfully underwent robotic prostatectomy at our institution. In five patients, standard transperitoneal robotic approach was performed. In one patient, robotic transperineal approach was mandatory. Median operative time was 282 min (86-460). Median estimated blood loss was 325 mL (50-1000). Two patients had positive surgical margins. One patient was found with nodal metastasis at final pathology. Neither perioperative nor postoperative complications were reported. At last follow-up, PSA was undetectable in 5/6 patients. Even after previous aborted prostatectomy, robot-assisted prostatectomy is feasible, with acceptable results. The case-by-case tailoring of the technique is the key for a successful intervention.

Identifiants

pubmed: 30159831
doi: 10.1007/s11701-018-0870-x
pii: 10.1007/s11701-018-0870-x
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407-412

Références

J Urol. 2002 Feb;167(2 Pt 1):637-8
pubmed: 11792935
Urology. 2006 Apr;67(4):774-9
pubmed: 16566979
N Engl J Med. 2008 Mar 20;358(12):1250-61
pubmed: 18354103
JSLS. 2009 Apr-Jun;13(2):142-7
pubmed: 19660206
Urology. 2010 May;75(5):1079-82
pubmed: 19896178
Urology. 2010 Nov;76(5):1125-9
pubmed: 20708782
Curr Urol Rep. 2011 Jun;12(3):229-36
pubmed: 21365234
Korean J Urol. 2015 Feb;56(2):131-7
pubmed: 25685300
Curr Urol. 2015 Sep;8(3):156-61
pubmed: 26889136
J Robot Surg. 2013 Sep;7(3):301-4
pubmed: 27000927
Urology. 2016 Aug;94:129-38
pubmed: 27233935
BJU Int. 2016 Nov;118(5):829-833
pubmed: 27410172
Lancet. 2016 Sep 10;388(10049):1027-1028
pubmed: 27474377
Oncology (Williston Park). 2017 May 15;31(5):333-40, 345
pubmed: 28512731
J Urol. 2018 Apr;199(4):990-997
pubmed: 29331546
Eur Urol Focus. 2018 Sep;4(5):669-673
pubmed: 29914841
Arab J Urol. 2018 May 24;16(3):302-306
pubmed: 30147958
Am J Surg. 1973 Sep;126(3):345-53
pubmed: 4580750

Auteurs

Jaya Sai Chavali (JS)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA.

Juan Garisto (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA.

Riccardo Bertolo (R)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA.

Jose Agudelo (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA.

Julien Dagenais (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA.

Jihad Kaouk (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q10, Cleveland, OH, 44195, USA. kaoukj@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH